
THE GLOBAL BREAST CANCER COMMUNITY
See the realities faced by patients with metastatic breast cancer (mBC) around the world and view some local initiatives to drive awareness and fight this disease.
Great progress comes through great collaboration. That’s why Pfizer awards grants, supports partnerships, and helps create resources around the globe to raise awareness and further extend the fight against breast cancer.
Pfizer has committed £10 million (USD $15M) over 3 years to fund research proposed by the Breast Cancer Now Catalyst Programme. The Programme allows the scientific community to propose research projects based on their insights into patient needs and understanding of cancer therapies, bringing together industry, researchers, and funders to advance the development of breast cancer treatments.
Yeliz is a 40-year-old woman living with mBC in Istanbul, Turkey. Hear her talk about bringing awareness to the global mBC landscape from diagnosis to treatment for all those impacted.
Great progress comes through great collaboration. That’s why Pfizer awards grants, supports partnerships, and helps create resources around the globe to raise awareness and further extend the fight against breast cancer.
Meet Amelia, a 51-year-old woman with mBC living in Aragón, Spain. Hear her talk about her diagnosis and how her friends and family helped support her throughout the process.
Great progress comes through great collaboration. That’s why Pfizer awards grants, supports partnerships, and helps create resources around the globe to raise awareness and further extend the fight against breast cancer.
Great progress comes through great collaboration. That’s why Pfizer awards grants, supports partnerships, and helps create resources around the globe to raise awareness and further extend the fight against breast cancer.
Some adults are fighting metastatic breast cancer (mBC). Others have loved ones with a new diagnosis. No matter their relationship with the disease, Me & mBC aims to help all those affected by offering solutions that are right for them. Our hope is that this site encourages all visitors to make the most of every day.
Breast Cancer Matters brings together the voices and stories of those working every day to improve the lives of women living with breast cancer (BC) and metastatic breast cancer (mBC). Physicians, patients, advocates, researchers, organizations, institutions, and decision makers provide their personal perspectives on BC and mBC and where improvements are needed.
Great progress comes through great collaboration. That’s why Pfizer awards grants, supports partnerships, and helps create resources around the globe to raise awareness and further extend the fight against breast cancer.
A Story Half Told is an initiative by Pfizer in partnership with advocates, patients and healthcare professionals that aims to elevate public understanding of metastatic breast cancer, dispel misperceptions, combat stigma and expand the breast cancer conversation to be more inclusive of metastatic breast cancer.
The ASPIRE program underscores Pfizer’s commitment to supporting investigators in advancing their academic research in advanced breast cancer and other therapeutic areas.
Since 2014, Pfizer and the Avon Breast Cancer Crusade have partnered to establish the Avon-Pfizer Metastatic Breast Cancer Grants Program to address the gaps in support available to women and men living with mBC.
BCRF has received a 3-year, $15 million grant from Pfizer, along with access to all of Pfizer’s marketed and pipeline assets, to support its Drug Research Collaborative. The collaborative offers a new model for bridging the gap between academic investigators and the industry partners who can provide access to developmental oncology drugs.
The program will initially support 6 laboratory studies and 3 clinical trials that will collectively benefit nearly 400 patients with metastatic disease. The clinical studies will be conducted and managed by the Translational Breast Cancer Research Consortium (TBCRC).
Meet Esther, a 33-year-old woman with mBC living in Mexico City, Mexico. Hear her talk about her diagnosis and the strength she found in a support system.
Great progress comes through great collaboration. That’s why Pfizer awards grants, supports partnerships, and helps create resources around the globe to raise awareness and further extend the fight against breast cancer.
Meet Elfriede, a 61-year-old woman from Saõ Paolo, Brazil. Hear her mBC story from diagnosis to treatment, and her support along the way.
Great progress comes through great collaboration. That’s why Pfizer awards grants, supports partnerships, and helps create resources around the globe to raise awareness and further extend the fight against breast cancer.
The Seeding Progress and Resources for the Cancer Community: Metastatic Breast Cancer Challenge (SPARC MBC Challenge) is an initiative of the Union for International Cancer Control (UICC) supported by Pfizer that aims to empower advocacy groups, hospital networks, support groups, and other organizations worldwide as they initiate projects to address the specific needs of women living with metastatic breast cancer.
Grants are awarded for projects focused on closing the gap in information, support, awareness, and policy between metastatic breast cancer and early breast cancer, as well as helping reduce the number of women first diagnosed at the metastatic stage of the disease.